369 results on '"Reis-Filho, J. S."'
Search Results
52. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast
53. The impact of expression profiling on prognostic and predictive testing in breast cancer
54. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma
55. Collagenous spherulosis in an adenomyoepithelioma of the breast
56. Salivary gland-like tumours of the breast: surgical and molecular pathology
57. p63 expression in sarcomatoid/metaplastic carcinomas of the breast
58. p63 staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast
59. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma
60. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer
61. Differential Ki67 and bcl-2 immunoexpression in solid–glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
62. Angiogenesis in lymph node metastases
63. April 2001: A 70 year old woman with recurrent meningioma
64. ESR1 and endocrine therapy resistance: more than just mutations
65. Functional characterization of EMSY gene amplification in human cancers
66. Somatic mitochondrial DNA disruptive mutations are modifiers of tumourigenesis that correlate with low genomic instability in pituitary adenomas
67. Emerging therapeutic targets in endometrial cancer
68. Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
69. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
70. Beyond triple-negative breast cancer: the need to define new subtypes
71. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein
72. PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study
73. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study
74. PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors
75. Do Chromosome 17 Centromere Copy Numbers Predict Polysomy? A Fluorescence In Situ Hybridization and Microarray-Based CGH Analysis
76. Molecular diagnosis in breast cancer
77. Back to the Basis: Breast Cancer Heterogeneity From an Etiological Perspective
78. Validation of blood-based molecular biomarkers
79. Erratum: DICER1 hotspot mutations in non-epithelial gonadal tumours
80. DICER1 hotspot mutations in non-epithelial gonadal tumours
81. Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers
82. Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies
83. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas
84. Use of topoisomerase II alpha (TOP2A) protein overexpression to predict response to anthracycline-based chemotherapy.
85. Bcl2 expression and prediction of outcomes to anthracycline-based neoadjuvant chemotherapy in ER-positive breast cancer and to nonanthracycline adjuvant therapy.
86. Bcl2 as a surrogate prognostic and predictive marker in triple-negative breast cancer.
87. Nuclear NF- B/p65 expression and response to neoadjuvant chemotherapy in breast cancer
88. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome
89. Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome
90. Nuclear NF-kb/p65 expression and response to neoadjuvant chemotherapy in breast cancer.
91. Preclinical evaluation of PARP inhibition as a treatment for endometrioid endometrial carcinomas.
92. Use of microarray-based comparative genomic hybridization analysis to identify prognostic subgroups of ovarian clear cell carcinomas.
93. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas)
94. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
95. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks
96. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
97. Expression profiling technology: its contribution to our understanding of breast cancer
98. Triple negative tumours: a critical review
99. Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride
100. c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.